Cargando…

Letter to the Editor Regarding a Multicentric Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia

Detalles Bibliográficos
Autores principales:	Ito, Shun, Banno, Masahiro, Okazaki, Yuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684857/ https://www.ncbi.nlm.nih.gov/pubmed/36414884 http://dx.doi.org/10.1007/s40121-022-00728-3

Ejemplares similares

Response to “Letter to the Editor Regarding a Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia”
por: Mantelli, Flavio
Publicado: (2022)

A Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia
por: Landoni, Giovanni, et al.
Publicado: (2022)

Efficacy and Safety of Reparixin in Patients with Severe COVID-19 Pneumonia: A Phase 3, Randomized, Double-Blind Placebo-Controlled Study
por: Piemonti, Lorenzo, et al.
Publicado: (2023)

Multiple anti-tumor effects of Reparixin on thyroid cancer
por: Liotti, Federica, et al.
Publicado: (2017)

Letter to Editor Regarding the OCEAN Study [Letter]
por: Yawn, Barbara P, et al.
Publicado: (2021)

The protective effects of reparixin against endothelial ischemia-reperfusion injury
por: Thitiwuthikiat, Piyanuch, et al.
Publicado: (2022)

Letter to the Editor Regarding Vaping Article
por: Spitz, Rabbi Yehuda
Publicado: (2019)

Letter to the Editor Regarding “Efficacy and safety of adjunctive corticosteroids in the treatment of severe community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials”
por: Wang, Shengfeng, et al.
Publicado: (2023)

Letter to editor regarding “comparison of efficacy of haloperidol and olanzapine in the treatment of delirium”
por: Kumar, Pawan, et al.
Publicado: (2019)

Letter to the Editor regarding Meta-analysis of the efficacy of gabapentin: a response
por: Masoud, Ahmed Taher, et al.
Publicado: (2022)

Response letter regarding the letter to the editors by Brown et al.
por: Taylor, Sylvia, et al.
Publicado: (2016)

Letter to the editor: Regarding the editorial by Penttinen and Friede
por: Fry, Alicia M, et al.
Publicado: (2016)

Letter to the Editor Regarding “Letter to the Editor: Spinal and Neurosurgical Publications During the COVID-19 Era”
por: Akhaddar, Ali, et al.
Publicado: (2020)

Letter to the editor regarding “Coexistence of neurological diseases with Covid-19 pneumonia during the pandemic period”
por: Serna-Hernandez, Juan Martin, et al.
Publicado: (2021)

Letter to the Editor regarding “Missed cerebrovascular events during prolonged sedation for COVID-19 pneumonia”
por: Ortega-Sierra, Michael Gregorio, et al.
Publicado: (2021)

Letter to the Editor Regarding “Minimally Invasive Treatment for Benign Parathyroid Lesions: Treatment Efficacy and Safety Based on Nodule Characteristics”
por: Sim, Jung Suk
Publicado: (2021)

Letter to editor regarding “The efficacy and safety of tranexamic acid in high tibial osteotomy: a systematic review and meta-analysis”
por: Fang, Qian, et al.
Publicado: (2021)

Letter to the editor regarding “The efficacy and safety of infliximab and calcineurin inhibitors in steroid-refractory UC patients: A meta-analysis”
por: Zhu, Qingcheng, et al.
Publicado: (2022)

The effect of reparixin on survival in patients at high risk for in-hospital mortality: a meta-analysis of randomized trials
por: Landoni, Giovanni, et al.
Publicado: (2022)

Letter to the Editor Regarding: A Comprehensive Review on Copemyl(®)
por: Comi, Giancarlo, et al.
Publicado: (2018)

Letter to the editor regarding “Rotavirus infection beyond the gut”
por: Orrico-Sánchez, Alejandro, et al.
Publicado: (2019)

Letter to the Editor: Regarding “The Role of Obesity in Pediatric Orthopedics”
por: Rehm, Andreas, et al.
Publicado: (2020)

Letter to the editor regarding the paper “Tick infestation of the eyelid”
por: Dantas-Torres, Filipe
Publicado: (2020)

Letter to the Editor: Regarding COVID-19 in Children with Asthma
por: Özdemir, Öner
Publicado: (2021)

Letter to the editor regarding the article of Chen et al.
por: Islamoglu, Mehmet Sami, et al.
Publicado: (2022)

Letter to the Editor Regarding “Ultrasound Features of Adhesive Capsulitis”
por: Boudier-Revéret, Mathieu, et al.
Publicado: (2022)

Letter to the editor regarding “Selfies: A boon or bane?”
por: Kazerooni, Rashid
Publicado: (2022)

Letter to the Editor Regarding: Evolving Business Models in Orthotics
por: Laakso, L.
Publicado: (2022)

Letter to the editor regarding “unusual extraneural metastasis of glioblastoma”
por: Waack, Andrew Leland, et al.
Publicado: (2023)

Letter to Editor regarding “Unusual Presentation of Spontaneous Chylothorax”
por: Varghese, Anjali Rachel, et al.
Publicado: (2022)

Response to the Letter to Editor
por: Tsutsui, Yuji
Publicado: (2018)

Letter to the Editor Regarding Efficacy and Safety of Diclofenac and Capsaicin Gel in Patients with Acute Back/Neck Pain: A Multicenter Randomized Controlled Study
por: Schwartz, Ruben, et al.
Publicado: (2020)

In reply to the letter to the editor regarding “The efficacy and safety of tranexamic acid in high tibial osteotomy: a systematic review and meta-analysis”
por: Ma, Jimin, et al.
Publicado: (2021)

Letter to the editor regarding ‘A systemic review and meta-analysis on the efficacy and safety of ferumoxytol for anemia in chronic kidney disease patients’
por: Li, Linqiang, et al.
Publicado: (2023)

Letter to the editor regarding the study “The effectiveness of gabapentin and gabapentin/montelukast combination compared with dextromethorphan in the improvement of COVID‐19‐related cough: A randomized, controlled clinical trial”
por: Ito, Shun, et al.
Publicado: (2022)

Reply to Letter to the Editor: Regarding “The Role of Obesity in Pediatric Orthopedics”
por: Nowicki, Philip, et al.
Publicado: (2020)

Letter to the editor regarding “disparities in telemedicine during COVID‐19”
por: De, Brian, et al.
Publicado: (2022)

The CXCR1/CXCR2 Inhibitor Reparixin Alters the Development of Myelofibrosis in the Gata1 (low) Mice
por: Verachi, Paola, et al.
Publicado: (2022)

Author’s Response to: ‘Letter to the Editor Regarding Efficacy and Safety of Diclofenac and Capsaicin Gel in Patients with Acute Back/Neck Pain: A Multicenter Randomized Controlled Study’
por: Weiser, Thomas W., et al.
Publicado: (2020)

Letter to the Editor regarding article “Electrocardiographic markers of increased risk of sudden cardiac death in patients with COVID‐19 pneumonia”
por: Jiang, Fenglin
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oqq8hetfhpkq7decf6bii4f9f2